This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sowers, J. R. Articles by Vlachis, N. Search for Related Content PubMed PubMed Citation Articles by Sowers, J. R. Articles by Vlachis, N.

Hypertension, Vol 4, 686-691, Copyright © 1982 by American Heart Association

ARTICLES

Blood pressure and hormone changes associated with weight reduction in the obese

JR Sowers, M Nyby, N Stern, F Beck, S Baron, R Catania and N Vlachis

This study examines factors modulating blood pressure reduction in obese patients undergoing weight reduction on a low calorie protein diet. Plasma norepinephrine (NE) was correlated (r = 0.65, p less than 0.01) with blood pressure in 20 obese patients prior to weight loss. Reductions in blood pressure levels following upright posture and isometric handgrip exercise were related to reduction in NE levels after these maneuvers. While plasma epinephrine levels declined in parallel with NE levels, plasma dopamine actually increased (p less than 0.05) during the first 2 weeks of caloric restriction. Prior to weight loss the obese patients demonstrated a significant rise in prolactin levels following posture and exercise, but following caloric restriction this was not observed. Levels of plasma renin activity (PRA) and aldosterone obtained after posture and exercise maneuvers were reduced after 8 weeks of caloric restriction, and reductions in PRA were related to reductions in NE (r = 0.56, p less than 0.01). Reductions in blood pressure in association with caloric restriction in these obese patients seems to result, in part, from reduced sympathetic nervous system activity as well as secondary effects of reduced adrenergic activity on renal sodium excretion and the renin-angiotensin- aldosterone axis.

This article has been cited by other articles:

				A. H. Siddiqui and T. Hussain Enhanced AT1 receptor-mediated vasocontractile response to ANG II in endothelium-denuded aorta of obese Zucker rats Am J Physiol Heart Circ Physiol, April 1, 2007; 292(4): H1722 - H1727. [Abstract] [Full Text] [PDF]

				S. D. Stocker, R. Meador, and J. M. Adams Neurons of the Rostral Ventrolateral Medulla Contribute to Obesity-Induced Hypertension in Rats Hypertension, March 1, 2007; 49(3): 640 - 646. [Abstract] [Full Text] [PDF]

				M. Bochud, J. Nussberger, P. Bovet, M. R. Maillard, R. C. Elston, F. Paccaud, C. Shamlaye, and M. Burnier Plasma Aldosterone Is Independently Associated With the Metabolic Syndrome Hypertension, August 1, 2006; 48(2): 239 - 245. [Abstract] [Full Text] [PDF]

				M. Nangaku, Y. Izuhara, N. Usuda, R. Inagi, T. Shibata, S. Sugiyama, K. Kurokawa, C. van Ypersele de Strihou, and T. Miyata In a type 2 diabetic nephropathy rat model, the improvement of obesity by a low calorie diet reduces oxidative/carbonyl stress and prevents diabetic nephropathy Nephrol. Dial. Transplant., December 1, 2005; 20(12): 2661 - 2669. [Abstract] [Full Text] [PDF]

				L. M. Hunt, E. W. Hogeland, M. K. Henry, and S. J. Swoap Hypotension and bradycardia during caloric restriction in mice are independent of salt balance and do not require ANP receptor Am J Physiol Heart Circ Physiol, October 1, 2004; 287(4): H1446 - H1451. [Abstract] [Full Text] [PDF]

				K. P. Davy and J. E. Hall Obesity and hypertension: two epidemics or one? Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2004; 286(5): R803 - R813. [Abstract] [Full Text] [PDF]

				D. A. Calhoun, M. K. Nishizaka, M. A. Zaman, and S. M. Harding Aldosterone Excretion Among Subjects With Resistant Hypertension and Symptoms of Sleep Apnea Chest, January 1, 2004; 125(1): 112 - 117. [Abstract] [Full Text] [PDF]

				C. A. Bickel, J. G. Verbalis, M. A. Knepper, and C. A. Ecelbarger Increased renal Na-K-ATPase, NCC, and beta -ENaC abundance in obese Zucker rats Am J Physiol Renal Physiol, October 1, 2001; 281(4): F639 - F648. [Abstract] [Full Text] [PDF]

				A. M Sharma and S. Engeli The renin-angiotensin system in obesity hypertension Journal of Renin-Angiotensin-Aldosterone System, March 1, 2001; 2(1_suppl): S114 - S119. [PDF]

				L. Benthem, K. Keizer, C. H. Wiegman, S. F. de Boer, J. H. Strubbe, A. B. Steffens, F. Kuipers, and A. J. W. Scheurink Excess portal venous long-chain fatty acids induce syndrome X via HPA axis and sympathetic activation Am J Physiol Endocrinol Metab, December 1, 2000; 279(6): E1286 - E1293. [Abstract] [Full Text] [PDF]

				T. D. Williams, J. B. Chambers, O. L. May, R. P. Henderson, M. E. Rashotte, and J. M. Overton Concurrent reductions in blood pressure and metabolic rate during fasting in the unrestrained SHR Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2000; 278(1): R255 - R262. [Abstract] [Full Text] [PDF]

				M. Pelat, P. Verwaerde, C. Merial, J. Galitzky, M. Berlan, J.-L. Montastruc, and J.-M. Senard Impaired Atrial M2-Cholinoceptor Function in Obesity-Related Hypertension Hypertension, November 1, 1999; 34(5): 1066 - 1072. [Abstract] [Full Text] [PDF]

				A. P. Rocchini, H. Z. Mao, K. Babu, P. Marker, and A. J. Rocchini Clonidine Prevents Insulin Resistance and Hypertension in Obese Dogs Hypertension, January 1, 1999; 33(1): 548 - 553. [Abstract] [Full Text] [PDF]

				E. Muscelli, S. Camastra, C. Catalano, A. Q. Galvan, D. Ciociaro, S. Baldi, and E. Ferrannini Metabolic and Cardiovascular Assessment in Moderate Obesity: Effect of Weight Loss J. Clin. Endocrinol. Metab., September 1, 1997; 82(9): 2937 - 2943. [Abstract] [Full Text] [PDF]

				J. M. Overton, J. M. VanNess, and R. M. Casto Food Restriction Reduces Sympathetic Support of Blood Pressure in Spontaneously Hypertensive Rats J. Nutr., April 1, 1997; 127(4): 655 - 660. [Abstract] [Full Text]

				M. Alonso-Galicia, M. W. Brands, D. H. Zappe, and J. E. Hall Hypertension in Obese Zucker Rats: Role of Angiotensin II and Adrenergic Activity Hypertension, December 1, 1996; 28(6): 1047 - 1054. [Abstract] [Full Text]

				T. Ikeda, T. Gomi, N. Hirawa, J. Sakurai, and N. Yoshikawa Improvement of Insulin Sensitivity Contributes to Blood Pressure Reduction After Weight Loss in Hypertensive Subjects With Obesity Hypertension, May 1, 1996; 27(5): 1180 - 1186. [Abstract] [Full Text]

				M. Alonso-Galicia, T. M. Dwyer, G. A. Herrera, and J. E. Hall Increased Hyaluronic Acid in the Inner Renal Medulla of Obese Dogs Hypertension, April 1, 1995; 25(4): 888 - 892. [Abstract] [Full Text]

				T. L. Goodfriend, B. Egan, K. Stepniakowski, and D. L. Ball Relationships Among Plasma Aldosterone, High-Density Lipoprotein Cholesterol, and Insulin in Humans Hypertension, January 1, 1995; 25(1): 30 - 36. [Abstract] [Full Text]

				E. REISIN, E. D. FROHLICH, F. H. MESSERLI, G. R. DRESLINSKI, F. G. DUNN, M. M. JONES, and H. M. BATSON Jr. Cardiovascular Changes After Weight Reduction in Obesity Hypertension Ann Intern Med, March 1, 1983; 98(3): 315 - 319. [Abstract] [PDF]